The Pilot Experimental Study of the Neuroprotective Effects of Exosomes in Extremely Low Birth Weight Infants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
To study the safety and efficacy of intranasal administration of exosomes derived from mesenchymal stromal cells on long-term neurodevelopmental outcome in extremely low birth weight infants born at gestational age 25/0-27/6 weeks.
Epistemonikos ID: c418e5c6a9a823a525e9d1cc663e490412a1140e
First added on: May 13, 2024